Moderated by David Tuveson, MD, PhD, Director of the Cold Spring Harbor Laboratory Cancer Center and Lustgarten Chief Scientist, this session will feature four renowned scientists presenting their latest research on risk assessment, detection & surveillance, and interception of early-stage pancreatic cancer.
The panel Q&A discussion will ask us to broaden our perspectives and delve deeper into the complex challenges and opportunities inherent in developing effective strategies for early detection and interception of this deadly disease.